CRANEWARE, the Scottish software company working in the US healthcare sector, has said its customers have experienced “unparalleled challenges” since Covid-19 began.

In trading for the year ended June 30, 2020, the board said it expects to report total revenue unmoved at $71.4 million, and Ebitda largely unchanged at around $24.5m, set against $24m, “in spite of the disruption of Covid-19”.

READ MORE: Edinburgh software company Craneware increases new sales in US market by a third

The Edinburgh-based firm also paid tribute “to the bravery and dedication we have seen from our customers, who have been at the forefront of dealing with this pandemic, selflessly serving their communities”.